Forget Gilead Sciences: Here Are 3 Better Biotech Stocks
Biogen Idec, Regeneron, and Amgen Inc. may be better bets than Gilead Sciences.
Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea
Regeneron reported its fourth-quarter and full-year numbers this morning. Here's what investors need to know.
Why MannKind Corporation's Shares Rocketed Higher Today
MannKind Corporation shares surge in the wake of Afrezza's commercialization.
3 All-or-Nothing Biotech Stocks We're Closely Watching
These three biotech stocks are counting on just one drug for success.